Lisinopril News
Novartis reports strong data on three of its hypertension drugs at the ASH 2006 (American society of Hypertension )
Swiss drug major Novartis AG says that three of its drugs for the treatment of high blood pressure saw strong data presented at the American Society of Hypertension's annual scientific meeting and exposition held in New York.
Novartis announces efficacy data on new investigational high blood pressure therapies at the American Society of Hypertension annual meeting
Comparative safety and blood pressure (BP)-lowering efficacy of a combination of amlodipine + valsartan and lisinopril + hydrochlorothiazide (HCTZ) in patients with stage 2 hypertension"
ATM-like device gives patients easy access to a generic Rx, saving them, and insurers, money
They look like ATMs but when the right password is punched in, prescription drugs - all generics - pop out instead of greenbacks. And soon these machines, which encourage doctors to prescribe generics instead of more expensive...
Lisinopril plus telmisartan may prevent diabetic nephropathy type 2 diabetes, hypertension
Lisinopril plus telmisartan may provide a new approach to diabetic nephropathy prevention in patients with type 2 diabetes, hypertension and microalbuminuria.